SPECTRACURE AB
2OKStockF
€0.00 ▼ 20.00%
12 juin 2026
2
SPECTRACURE AB
€0.00 ▼ 20.00%
12 juin 2026
2OKStockF

01 / À propos

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

Arberion
Loading market data